No photo of Thomas J Schnitzer

View Scopus Profile

Thomas J Schnitzer

  • 23225 Citations
1975 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Grants

Filter
Active
Active

Prot #TLC599A3005: A Phase 3, Randomized, Double-blind, Placebo- and Active-controlled Study to Evaluate the Efficacy and Safety of TLC599 in Patients with Osteoarthritis of the Knee

Schnitzer, T. J.

Premier Research International, LLC, Taiwan Liposome Company, Ltd

6/25/20 → 6/25/23

Project: Research project

Prot #R475-OA-1816: Study to Evaluate Arthroplasty Specimens in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

Schnitzer, T. J.

ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

5/14/19 → 5/14/22

Project: Research project

Prot #R475-OA-1758: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients with Pain due to Osteoarthritis of the Hip or Knee

Schnitzer, T. J.

inVentiv Health Clinical, Regeneron Pharmaceuticals, Inc.

2/21/19 → 2/21/22

Project: Research project

Prot #FX006-2018-015: A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Hip Osteoarthritis

Schnitzer, T. J.

Flexion Therapeutics, Inc.

2/6/19 → 2/6/22

Project: Research project

Brain Pathophysiology of Osteoarthritis Pain

Apkarian, A., Griffith, J. W., Kahnt, T., Manning, D. W., Parrish, T. B. & Schnitzer, T. J.

National Institute of Arthritis and Musculoskeletal and Skin Diseases

2/1/19 → 12/31/23

Project: Research project

Prot #TGC-15302/KTG-15302: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy and Effectiveness of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee

Schnitzer, T. J.

Parexel, Kolon TissueGene, Inc.

1/28/19 → 1/28/24

Project: Research project

Prot #CL2-201086-002/GLPG1972-CL-201: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controll

Schnitzer, T. J.

Medpace Clinical Research LLC, Galapagos NV

12/4/18 → 12/4/21

Project: Research project

Center for chronic pain and drug abuse

Apkarian, A., Awatramani, R., Drenan, R. M., Graves, S. M., Griffith, J. W., Huang, L., Jovasevic, V., Martina, M., Miller, R. J., Parrish, T. B., Procissi, D., Radulovic, J., Rodes, M. E., Schnitzer, T. J., Surmeier Jr, D. J. & Walega, D. R.

National Institute on Drug Abuse

9/1/18 → 6/30/23

Project: Research project

Prot# BA058-05-019: A Randomized, Double-blind, Placebo-controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide-SC for the Treatment of Men with Osteoporosis

Schnitzer, T. J.

ICON Clinical Research, LLC, Radius Health, Inc.

6/13/18 → 6/13/21

Project: Research project

D-Cycloserine for the Treatment of Chronic, Refractory Low Back Pain

Apkarian, A., Griffith, J. W. & Schnitzer, T. J.

U.S. Army Medical Research and Materiel Command

9/30/17 → 9/29/21

Project: Research project

Prot #KF7013-03: Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

Schnitzer, T. J.

Worldwide Clinical Trials, Inc., Grunenthal GmbH

1/17/17 → 1/17/22

Project: Research project

Prot #R475-PN-1523: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip

Schnitzer, T. J.

ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.

5/12/16 → 5/12/22

Project: Research project

Prot #AXS02-K301: COAST-1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study- A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Kn

Schnitzer, T. J.

Axsome Therapeutics, Inc.

3/15/16 → 11/30/20

Project: Research project

Prot #R475-PN-1524: A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Moderate to Severe Chronic Low Back Pain

Schnitzer, T. J.

ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.

3/10/16 → 4/15/21

Project: Research project

Functional Performance Evaluation of the Northwestern University Flexible Sub-Ischial Vacuum (NU-FlexSIV) Socket for Persons with Transfemoral Amputation

Fatone, S. & Schnitzer, T. J.

U.S. Army Medical Research and Materiel Command

9/30/15 → 9/29/20

Project: Research project

Prot #A4091059: A Phase 3, Randomized, Double Blind, Placebo and Active Controlled, Multicenter, Parallel Group Study of the Analgesic Efficacy and Safety of Tanezumab in Adult Subjects with Chronic Low Back Pain

Schnitzer, T. J.

INC Research, LLC, Pfizer Inc.

9/11/15 → 9/11/21

Project: Research project

Prot #A4091058: A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

Schnitzer, T. J.

INC Research, LLC, Pfizer Inc.

8/25/15 → 8/31/21

Project: Research project

Prevention of Bone Loss after Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength and Use of Biomarkers to Guide Therapy

Griffith, J. W. & Schnitzer, T. J.

U.S. Army Medical Research and Materiel Command

9/30/14 → 3/28/21

Project: Research project